Status:
COMPLETED
Recovery of Patients From COVID-19 After Critical Illness
Lead Sponsor:
Australian and New Zealand Intensive Care Research Centre
Collaborating Sponsors:
The Alfred
Conditions:
COVID-19
Critical Illness
Eligibility:
All Genders
17+ years
Brief Summary
Patients who are critically ill with COVID-19 requiring life support in an intensive care unit (ICU) have increased risk of morbidity and mortality. Currently the ICU community does not know what effe...
Eligibility Criteria
Inclusion
- COVID-19 patients who have been admitted to ICU for \> 24 hours
- Patients aged over 17 years
- Persistent critical illness cohort
- As above
- An ICU admission of at least 10 consecutive days
Exclusion
- Previous enrolment in this study in a prior ICU admission
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2022
Estimated Enrollment :
536 Patients enrolled
Trial Details
Trial ID
NCT04401254
Start Date
July 1 2020
End Date
July 30 2022
Last Update
September 28 2022
Active Locations (29)
Enter a location and click search to find clinical trials sorted by distance.
1
Canberra Hospital
Garran, Australian Capital Territory, Australia, 2605
2
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia, 2050
3
Concord Hospital
Concord, New South Wales, Australia, 2139
4
St Vincent's Hospital Sydney
Darlinghurst, New South Wales, Australia, 2010